Open AccessHepatic AL Amyloidosis Without Significant Light Chain Elevation in a Patient Treated with CyBorD Plus Daratumumab
Author(s) -
Brad Rybinski,
Mehmet H. Kocoglu
Publication year - 2021
Publication title -
american journal of case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.247
H-Index - 18
ISSN - 1941-5923
DOI - 10.12659/ajcr.933241
Subject(s) - daratumumab , al amyloidosis , amyloidosis , immunoglobulin light chain , medicine , elevation (ballistics) , dermatology , oncology , gastroenterology , multiple myeloma , immunology , bortezomib , antibody , structural engineering , engineering
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom